Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	At The Market Sales Agreement [Member]	Common Stock [Member]	Common Stock [Member] At The Market Sales Agreement [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] At The Market Sales Agreement [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2022	$ 107,459		$ 60		$ 317,590		$ (122)	$ (210,069)
Beginning Balance (in shares) at Dec. 31, 2022			59,943,430
Stock-based compensation	1,183				1,183
Issuance of common stock from exercise of stock options	70				70
Issuance of common stock from exercise of stock options (in shares)			136,914
Issuance of common stock from Employee Stock Purchase Plan	33				33
Issuance of common stock from Employee Stock Purchase Plan (in shares)			19,273
Issuance of common stock from pre-funded warrant exercise			$ 3		(3)
Issuance of common stock from pre-funded warrant exercise (in shares)			2,998,838
Unrealized losses on available-for-sale marketable securities	(126)						(126)
Net loss	(13,546)							(13,546)
Ending Balance at Jun. 30, 2023	95,073		$ 63		318,873		(248)	(223,615)
Ending Balance (in shares) at Jun. 30, 2023			63,098,455
Beginning Balance at Mar. 31, 2023	101,732		$ 60		318,230		(88)	(216,470)
Beginning Balance (in shares) at Mar. 31, 2023			60,065,408
Stock-based compensation	606				606
Issuance of common stock from exercise of stock options	7				7
Issuance of common stock from exercise of stock options (in shares)			14,936
Issuance of common stock from Employee Stock Purchase Plan	33				33
Issuance of common stock from Employee Stock Purchase Plan (in shares)			19,273
Issuance of common stock from pre-funded warrant exercise			$ 3		(3)
Issuance of common stock from pre-funded warrant exercise (in shares)			2,998,838
Unrealized losses on available-for-sale marketable securities	(160)						(160)
Net loss	(7,145)							(7,145)
Ending Balance at Jun. 30, 2023	95,073		$ 63		318,873		(248)	(223,615)
Ending Balance (in shares) at Jun. 30, 2023			63,098,455
Beginning Balance at Dec. 31, 2023	82,547		$ 68		321,642		(29)	(239,134)
Beginning Balance (in shares) at Dec. 31, 2023			68,283,699
Stock-based compensation	1,850				1,850
Issuance of common stock from exercise of stock options	$ 218				218
Issuance of common stock from exercise of stock options (in shares)	129,518		129,518
Issuance of common stock from Employee Stock Purchase Plan	$ 34				34
Issuance of common stock from Employee Stock Purchase Plan (in shares)			30,675
Issuance of common stock, net of commissions and allocated fees, less issuance costs		$ 4,834		$ 2		$ 4,832
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)				1,474,926
Issuance of common stock from pre-funded warrant exercise			$ 3		(3)
Issuance of common stock from pre-funded warrant exercise (in shares)			2,673,099
Unrealized losses on available-for-sale marketable securities	(55)						(55)
Net loss	(23,254)							(23,254)
Ending Balance at Jun. 30, 2024	66,174		$ 73		328,573		(84)	(262,388)
Ending Balance (in shares) at Jun. 30, 2024			72,591,917
Beginning Balance at Mar. 31, 2024	72,334		$ 69		322,368		(67)	(250,036)
Beginning Balance (in shares) at Mar. 31, 2024			68,960,167
Stock-based compensation	1,127				1,127
Issuance of common stock from exercise of stock options	214				214
Issuance of common stock from exercise of stock options (in shares)			126,887
Issuance of common stock from Employee Stock Purchase Plan	34				34
Issuance of common stock from Employee Stock Purchase Plan (in shares)			30,675
Issuance of common stock, net of commissions and allocated fees, less issuance costs		$ 4,834		$ 2		$ 4,832
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)				1,474,926
Issuance of common stock from pre-funded warrant exercise			$ 2		(2)
Issuance of common stock from pre-funded warrant exercise (in shares)			1,999,262
Unrealized losses on available-for-sale marketable securities	(17)						(17)
Net loss	(12,352)							(12,352)
Ending Balance at Jun. 30, 2024	$ 66,174		$ 73		$ 328,573		$ (84)	$ (262,388)
Ending Balance (in shares) at Jun. 30, 2024			72,591,917